Similar Papers

Paper Title
Journal
Date
Author
TURALIO® Risk Evaluation and Mitigation Strategy Program (tREMS): 3-year retrospective hepatic safety assessment.
Charles Dharmani ... Maribel Salas
Future oncology (London, England) | VOL. 20
Charles Dharmani, et. al.Charles Dharmani ... Maribel Salas
18 Jul 2024
Macitentan: Endothelin receptor antagonist
Joe Sheffer
Pharmacy Today | VOL. 19
Joe ShefferJoe Sheffer
01 Dec 2013
Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies
Amir Sarayani ... Almut G Winterstein
American Journal of Obstetrics and Gynecology | VOL. 227
Amir Sarayani, et. al.Amir Sarayani ... Almut G Winterstein
12 Jan 2022
The Xyrem® (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017.
Michael J Strunc ... Judi Profant
Drugs - real world outcomes | VOL. 8
Michael J Strunc, et. al.Michael J Strunc ... Judi Profant
13 Jan 2021
View more papers

More From: American Journal of Health-System Pharmacy

Paper Title
Journal
Date
Author
2024 ASHP Midyear Clinical Meeting Poster Abstracts
-
American Journal of Health-System Pharmacy | VOL. -
--
08 Jan 2025
Impact of obtaining prescriptions upon discharge on hospital readmissions in a large healthcare system
Ethan Robarts ... Emily Ong
American Journal of Health-System Pharmacy | VOL. -
Ethan Robarts, et. al.Ethan Robarts ... Emily Ong
03 Jan 2025
Pharmacy technician education and training: Highlighting the partnership among a state pharmacy association, local community college, and healthcare system
Richard Yik ... Marissa C Salvo
American Journal of Health-System Pharmacy | VOL. -
Richard Yik, et. al.Richard Yik ... Marissa C Salvo
02 Jan 2025
Inavolisib
-
American Journal of Health-System Pharmacy | VOL. -
--
24 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.